New Medicare Program Offers Weight Loss Drug Discounts for Seniors

Want the full story?
Read the complete article at KVIA
AI Summary
A new federal initiative, the Medicare GLP-1 Bridge, will provide significant discounts on popular weight loss medications for eligible seniors starting Wednesday. Adults aged 18 and older who participate in Medicare Part D and meet specific health criteria, such as having a BMI of 35 or higher, can access medications like semaglutide and tirzepatide for just $50 per month. This program aims to address the rising obesity rates among older adults, which have doubled in recent decades, and is expected to run until December 2027. While the program could benefit millions, experts advise that potential users should consider the implications of using these medications beyond just cost.
Key Details: • Eligibility requires a BMI of 35 or higher, or 27-34.9 with obesity-related health issues. • Medications available include semaglutide (Wegovy) and tirzepatide (Zepbound). • The program runs through December 2027, providing discounts to Medicare participants. • 3.8 million Americans may qualify for the program based on recent data.